Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Equate Eye Allergy Relief Drops is an over-the-counter **ophthalmic combination product** marketed under Walmart's Equate private-label brand for temporary relief of **allergic conjunctival symptoms**, particularly eye **itching and redness** triggered by allergens such as pollen, ragweed, grass, animal hair, and dander. The sterile ophthalmic solution contains two **small-molecule** active ingredients: **naphazoline hydrochloride 0.02675%**, an alpha-adrenergic sympathomimetic vasoconstrictor that reduces conjunctival hyperemia by constricting superficial ocular blood vessels, and **pheniramine maleate 0.315%**, a first-generation antihistamine that blocks histamine signaling to relieve allergic itching. The product is positioned as comparable to Opcon-A and is supplied in 0.5 fl oz bottles for ophthalmic administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Equate Eye Allergy Relief Drops.